Skip to main content
Clinical Trials/NCT06990646
NCT06990646Not yet recruitingNot Applicable

VR-ACT After Stroke: a Feasibility RCT of a Virtual Reality Delivery of ACT for Pain Management and Mental Health in Patients With Chronic Post-Stroke Pain

University of Coimbra0 sites30 target enrollmentStarted: November 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
30
Primary Endpoint
Pain intensity

Study Overview

Brief Summary

This exploratory project aims to develop and pilot test, in a parallel group randomized controlled trial (RCT) design, the feasibility, acceptability, and preliminary efficacy of a self-management virtual reality (VR) 8-week program for pain management and mental health in patients with chronic post-stroke pain (CPSP), in two assessment moments (pre- to post-intervention).

Detailed Description

This project has three objectives: O1) to develop and test the feasibility and acceptability of a 8-week VR ACT program (VR-ACT) in a sample of CPSP patients; O2) to pilot test the efficacy of VR-ACT in improving pain, mental health, and adaptive psychological processes and skills, and in reducing the functional connectivity of the Triple Network (DMN, SN, and FPN); O3) To examine the cost-effectiveness of the VR-ACT. The current project will conduct a parallel group design Randomized Controlled Trial (RCT) and will follow a multi-method approach (qualitative and quantitative assessment).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •medical diagnosis of CPSP;
  • •age between 18 and 80;
  • •implicit de facto internet and computer literacy;
  • •willingness to comply with the study procedures.

Exclusion Criteria

  • •currently with active malignancy; -
  • •severe cognitive impairment;
  • •currently undergoing any psychological intervention or VR-delivered pain management program;
  • •current severe psychiatric symptoms (i.e., psychosis; severe depression; non-suicidal self-injury; suicide attempt in the last month);
  • •language impairment with severe comprehension deficit;
  • •history of photosensitive epilepsy or previous experience of severe simulator sickness;
  • •other neurological conditions (e.g., dementia; Parkinson´s).

Arms & Interventions

VR-ACT

Experimental

8 modules of 3D immersive skills training (2 targeting awareness regulation skills; 3 promoting acceptance; 3 focused on behavioral change and commitment to valued action)

Intervention: VR-ACT (Behavioral)

Sham-VR

Sham Comparator

8 2D non-immersive distracting video animations delivered through a VR headset

Intervention: Sham-VR (Behavioral)

Outcomes

Primary Outcomes

Pain intensity

Time Frame: From enrollment to the end of treatment at 8 weeks

- The Numeric Rating Scale (NRS)

Pain Impact

Time Frame: From enrollment to the end of treatment at 8 weeks

- Pain Disability Index (PDI)

Mental Health

Time Frame: From enrollment to the end of treatment at 8 weeks

Mental Health: - Depression Anxiety and Stress Scale (DASS-21)

Psychological and Physical Quality of Life

Time Frame: From enrollment to the end of treatment at 8 weeks

- World Health Organization Quality of Life - Bref (WHOQOL- Bref)

Secondary Outcomes

  • Mindful Awareness(From enrollment to the end of treatment at 8 weeks)
  • Emotional Regulation(From enrollment to the end of treatment at 8 weeks)
  • Psychological Flexibility(From enrollment to the end of treatment at 8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sérgio Andrade Carvalho

Doctor

University of Coimbra

Similar Trials